AVGO vs UTHR Stock Comparison
UTHR currently leads AVGO in this stock comparison, with AIQ scores of 76 vs 52. The clearest difference is risk resilience.
What is the main difference between AVGO and UTHR?
UTHR leads the current stock comparison as United Therapeutics Corporation, with the clearest separation coming from risk resilience and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Broadcom Inc. vs United Therapeutics Corporation
UTHR leads
UTHR leads by 24 AIQ points, primarily on Risk Resilience and Value, and the lead has widened from 16 points over 30 sessions. Wall Street currently favors AVGO on target upside.
Competitive: 4 of 6 evidence groups support UTHR, its lead is widening, and its current signal state is conflicted.
Broadcom Inc.
United Therapeutics Corporation
The Algovestiq AIQ Score currently favors UTHR over AVGO, 76 versus 52 as of Nov 15, 2026. UTHR's advantage is driven primarily by stronger risk resilience and value. UTHR also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors AVGO. 4 of 6 covered evidence groups favor UTHR today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. UTHR lead: Strengthening — the AIQ differential moved from 16 to 24 points over 30 sessions. UTHR leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.
Compare Broadcom Inc. and United Therapeutics Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare AVGO and UTHR against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience47 vs 83UTHR +36
- Value50 vs 78UTHR +28
- Momentum40 vs 68UTHR +28
- Quality69 vs 81UTHR +12
4 of 6 evidence groups favor UTHR. UTHR’s edge is concentrated in risk resilience and value.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum -2, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 6 active signals are unchanged.
Largest factor move: Momentum -1
New signals
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
UTHR's lead narrowed by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — AVGO and UTHR both carry a full feed there.
The central trade-off
UTHR (United Therapeutics Corporation): the stronger current systematic profile, led by risk resilience and value.
AVGO (Broadcom Inc.): the counter-case, on fundamentals, analyst expectations — but at materially higher volatility, 70% against 34.8%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
UTHRUTHR on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
AVGOAVGO on combined revenue and EPS growth.
Value
UTHRUTHR on the peer-relative Value factor, by 28 points.
Momentum
UTHRUTHR on the Momentum factor, by 28 points.
Lower downside
UTHRUTHR on Risk Resilience, by 36 points.
Analyst upside
AVGOAVGO on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors UTHR, analyst targets favor AVGO. That disagreement is the most useful thing on this page.
| Measure | AVGO | UTHR | Note |
|---|---|---|---|
| Implied upside to target | +48.5% | +16.3% | AVGO has more room |
| Target dispersion | +48.5% | +70.1% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 51 | 16 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor UTHR. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | UTHR | 52 vs 76 |
| Fundamentals | AVGOon balance | revenue growth 33.4% vs 6.3%; EPS growth 40.3% vs -22.5%; TTM ROE 13.1% vs 4.1%; gross margin 68.8% vs 86.3%; operating margin 48.4% vs 41.5% — AVGO takes 4 of 5 decided legs, not all of them |
| Valuation | UTHR | Value 50 vs 78 |
| Technicals | UTHR | Price vs 50-day 0.5% vs 9%; vs 200-day -5.6% vs 10% |
| Risk Resilience | UTHR | Risk Resilience 47 vs 83 |
| Analyst expectations | AVGO | Target upside 48.5% vs 16.3% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVGO and UTHR and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 24 points. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
- Analyst targets on the leader are widely dispersed. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on UTHR.
How the comparison changed
120 daily snapshots · May 27 – Nov 13UTHR lead: Strengthening — the AIQ differential moved from 16 to 24 points over 30 sessions.
- Today
- UTHR +24
- 52 vs 76
- 7 sessions ago
- UTHR +26
- 50 vs 76
- 30 sessions ago
- UTHR +16
- 55 vs 71
- 90 sessions ago
- UTHR +11
- 59 vs 70
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 2 bearish / 2 neutral, conflicted
Only AVGO
- Death Cross Active — bearish, trend, long horizon (6.38%)
- ADX Trend Weakening — neutral, trend, medium horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.14%)
- Accumulation Pattern — bullish, volume, medium horizon (1.18x)
- Beta Spike Warning — bearish, risk_regime, long horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
5 bullish / 2 bearish / 1 neutral, conflicted
Only UTHR
- Golden Cross Active — bullish, trend, long horizon (0.96%)
- 52-Week High Proximity — bullish, risk_regime, long horizon (2.5%)
- ADX Trend Strengthening — neutral, trend, medium horizon
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-10.6%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
- RSI Bearish Divergence — bearish, momentum, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
UTHR leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -4.76%, AIQ 0 points).
Price and the AIQ Score both moved down over the latest session (price -0.36%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1AVGO closes the Risk Resilience gap — currently 36 points behind, the largest single contributor to UTHR's edge.
- 2AVGO's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3UTHR's conflicting signal state resolves bearish — it currently carries 5 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
AVGO leads on balance| Metric | AVGO | UTHR |
|---|---|---|
| Revenue growth (YoY) | 33.4% | 6.3% |
| EPS growth (YoY) | 40.3% | -22.5% |
| Gross margin | 68.8% | 86.3% |
| Operating margin | 48.4% | 41.5% |
| Return on equity (TTM) | 13.1% | 4.1% |
| Debt to equity | 0.6 | 0 |
Performance
UTHR leads 5 of 6 windows| Metric | AVGO | UTHR |
|---|---|---|
| 1 week (5 sessions) | 18.2% | 5.2% |
| 1 month (20 sessions) | 5.6% | 10.9% |
| 3 months (63 sessions) | -11.6% | 16.3% |
| 6 months (126 sessions) | -18.4% | 4% |
| Year to date | 0.3% | 21.3% |
| 1 year (252 sessions) | -2.3% | 28.1% |
Technicals
UTHR has the stronger structure| Metric | AVGO | UTHR |
|---|---|---|
| RSI (14) | 53.2 | 58 |
| ADX (14) | 23 | 20.9 |
| Price vs 50-day | 0.5% | 9% |
| Price vs 200-day | -5.6% | 10% |
| Volatility (1M, annualized) | 70% | 34.8% |
Risk
UTHR is the more resilient| Metric | AVGO | UTHR |
|---|---|---|
| Beta | 2.21 | 0.42 |
| Sharpe ratio | 0.21 | 0.76 |
| Sortino ratio | 0.29 | 1.4 |
| Max drawdown | -39.5% | -20.9% |
| Current drawdown | -27.9% | -2.8% |
| Annualized volatility | 48.6% | 35% |
| Value at risk (95%) | -4.6% | -2.4% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AVGO or UTHR?
On the Algovestiq AIQ Score, UTHR is the stronger of the two as of Nov 15, 2026, scoring 76 against AVGO's 52. The edge comes from risk resilience and value. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AVGO or UTHR the better buy right now?
UTHR carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor UTHR over AVGO?
The composite weights Quality, Value, Momentum and Risk Resilience. UTHR leads Risk Resilience by 36 points; UTHR leads Value by 28 points; UTHR leads Momentum by 28 points. UTHR leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by AVGO simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.
Which has more analyst upside, AVGO or UTHR?
Analyst price targets imply +48.5% upside for AVGO and +16.3% for UTHR, so the Street currently favors AVGO. That points the opposite way to the AIQ Score, which favors UTHR. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AVGO or UTHR?
UTHR is the better-valued of the two on the peer-relative Value factor. UTHR on the peer-relative Value factor, by 28 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AVGO or UTHR?
AVGO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AVGO or UTHR?
UTHR on the Momentum factor, by 28 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AVGO or UTHR?
UTHR is the more resilient of the two, so the other name carries the higher downside risk. UTHR on Risk Resilience, by 36 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AVGO more profitable than UTHR?
The profitability evidence is mixed: gross margin 68.8% vs 86.3%; operating margin 48.4% vs 41.5%; ttm roe 13.1% vs 4.1%. AVGO leads on two measures and UTHR on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is UTHR's lead over AVGO getting stronger or weaker?
UTHR lead: Strengthening — the AIQ differential moved from 16 to 24 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the AVGO vs UTHR verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AVGO closes the Risk Resilience gap — currently 36 points behind, the largest single contributor to UTHR's edge; AVGO's Death Cross Active resolves — a bearish trend rule currently active against it; UTHR's conflicting signal state resolves bearish — it currently carries 5 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about AVGO and UTHR?
AVGO: 2 bullish / 2 bearish / 2 neutral, conflicted. UTHR: 5 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVGO is Death Cross Active (bearish, long horizon). On UTHR it is Golden Cross Active (bullish, long horizon).
Compare AVGO and UTHR with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.